Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRyota Toki, Masaya Sakamoto, Toru Takebayashi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Comment on Toki. Seasonal BMI amplitude and kidney function decline in Japanese adults with type 2 diabetes (JDDM 82)
10.2337/dc26-1311 · 2026
Comment on Toki. Seasonal BMI amplitude and risk of kidney function decline in Japanese adults with type 2 diabetes (JDDM 82)
10.2337/dc26-1227 · 2026
Seasonal BMI amplitude and risk of kidney function decline in Japanese adults with type 2 diabetes (JDDM 82)
10.2337/dc26-0082 · 2026
Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency
10.1053/j.ajkd.2019.06.009 · 2020
Considerations in the study of body mass index variability
10.1681/asn.2021060844 · 2021
Body composition in chronic kidney disease
2015
Empagliflozin and progression of kidney disease in type 2 diabetes
10.1056/nejmoa1515920 · 2016
Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes
10.1056/nejmoa2403347 · 2024
No additional external references are available.